These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 28143868)
1. Prebiopsy mp-MRI Can Help to Improve the Predictive Performance in Prostate Cancer: A Prospective Study in 1,478 Consecutive Patients. Wang R; Wang J; Gao G; Hu J; Jiang Y; Zhao Z; Zhang X; Zhang YD; Wang X Clin Cancer Res; 2017 Jul; 23(14):3692-3699. PubMed ID: 28143868 [No Abstract] [Full Text] [Related]
2. Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients. Washino S; Okochi T; Saito K; Konishi T; Hirai M; Kobayashi Y; Miyagawa T BJU Int; 2017 Feb; 119(2):225-233. PubMed ID: 26935594 [TBL] [Abstract][Full Text] [Related]
3. Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone. Niu XK; Li J; Das SK; Xiong Y; Yang CB; Peng T BMC Med Imaging; 2017 Feb; 17(1):11. PubMed ID: 28143433 [TBL] [Abstract][Full Text] [Related]
4. The combination of prostate imaging reporting and data system version 2 (PI-RADS v2) and periprostatic fat thickness on multi-parametric MRI to predict the presence of prostate cancer. Cao Y; Cao M; Chen Y; Yu W; Fan Y; Liu Q; Gao G; Zhao Z; Wang X; Jin J Oncotarget; 2017 Jul; 8(27):44040-44049. PubMed ID: 28476042 [TBL] [Abstract][Full Text] [Related]
5. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer. Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899 [TBL] [Abstract][Full Text] [Related]
6. Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative. Faiella E; Santucci D; Greco F; Frauenfelder G; Giacobbe V; Muto G; Zobel BB; Grasso RF Radiol Med; 2018 Feb; 123(2):143-152. PubMed ID: 29019021 [TBL] [Abstract][Full Text] [Related]
7. Could Magnetic Resonance Imaging Help to Identify the Presence of Prostate Cancer Before Initial Biopsy? The Development of Nomogram Predicting the Outcomes of Prostate Biopsy in the Chinese Population. Fang D; Zhao C; Ren D; Yu W; Wang R; Wang H; Li X; Yin W; Yu X; Yang K; Liu P; Shan G; Li S; He Q; Wang X; Xin Z; Zhou L Ann Surg Oncol; 2016 Dec; 23(13):4284-4292. PubMed ID: 27464612 [TBL] [Abstract][Full Text] [Related]
8. Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer. Salami SS; Vira MA; Turkbey B; Fakhoury M; Yaskiv O; Villani R; Ben-Levi E; Rastinehad AR Cancer; 2014 Sep; 120(18):2876-82. PubMed ID: 24917122 [TBL] [Abstract][Full Text] [Related]
9. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy]. Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131 [TBL] [Abstract][Full Text] [Related]
10. The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer Prediction. Distler FA; Radtke JP; Bonekamp D; Kesch C; Schlemmer HP; Wieczorek K; Kirchner M; Pahernik S; Hohenfellner M; Hadaschik BA J Urol; 2017 Sep; 198(3):575-582. PubMed ID: 28373135 [TBL] [Abstract][Full Text] [Related]
11. Toward an MRI-based nomogram for the prediction of transperineal prostate biopsy outcome: A physician and patient decision tool. Lee SM; Liyanage SH; Wulaningsih W; Wolfe K; Carr T; Younis C; Van Hemelrijck M; Popert R; Acher P Urol Oncol; 2017 Nov; 35(11):664.e11-664.e18. PubMed ID: 28801025 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Multiparametric Magnetic Resonance Imaging in Detection and Prediction of Prostate Cancer. Wang R; Wang H; Zhao C; Hu J; Jiang Y; Tong Y; Liu T; Huang R; Wang X PLoS One; 2015; 10(6):e0130207. PubMed ID: 26067423 [TBL] [Abstract][Full Text] [Related]
13. Predicting Benign Prostate Pathology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Men with a Prior Negative 12-core Systematic Biopsy: External Validation of a Prognostic Nomogram. Bjurlin MA; Renson A; Rais-Bahrami S; Truong M; Rosenkrantz AB; Huang R; Taneja SS Eur Urol Focus; 2019 Sep; 5(5):815-822. PubMed ID: 29802053 [TBL] [Abstract][Full Text] [Related]
14. Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL. Dwivedi DK; Kumar R; Dwivedi AK; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR J Magn Reson Imaging; 2018 May; 47(5):1227-1236. PubMed ID: 28872226 [TBL] [Abstract][Full Text] [Related]
15. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL. Kawamura K; Suzuki H; Kamiya N; Imamoto T; Yano M; Miura J; Shimbo M; Suzuki N; Nakatsu H; Ichikawa T Int J Urol; 2008 Jul; 15(7):598-603. PubMed ID: 18462353 [TBL] [Abstract][Full Text] [Related]
16. Can Prostate Imaging Reporting and Data System Version 2 reduce unnecessary prostate biopsies in men with PSA levels of 4-10 ng/ml? Xu N; Wu YP; Chen DN; Ke ZB; Cai H; Wei Y; Zheng QS; Huang JB; Li XD; Xue XY J Cancer Res Clin Oncol; 2018 May; 144(5):987-995. PubMed ID: 29504080 [TBL] [Abstract][Full Text] [Related]
17. Magnetic Resonance Imaging-Defined Prostate-Specific Antigen Density Significantly Improves the Risk Prediction for Clinically Significant Prostate Cancer on Biopsy. Bhat NR; Vetter JM; Andriole GL; Shetty AS; Ippolito JE; Kim EH Urology; 2019 Apr; 126():152-157. PubMed ID: 30580005 [TBL] [Abstract][Full Text] [Related]
18. [Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer]. Zuo MZ; Zhao WL; Wei CG; Zhang CY; Wen R; Gu YF; Li MJ; Zhang YY; Wu JF; Li X; Shen JK Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3693-3698. PubMed ID: 29325321 [No Abstract] [Full Text] [Related]
19. Assessment of prostate-specific antigen doubling time in prediction of prostate cancer on needle biopsy. Spurgeon SE; Mongoue-Tchokote S; Collins L; Priest R; Hsieh YC; Peters LM; Beer TM; Mori M; Garzotto M Urology; 2007 May; 69(5):931-5. PubMed ID: 17482937 [TBL] [Abstract][Full Text] [Related]
20. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy. Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]